{"disease":{"id":"glucagon-like-peptide-1-receptor-agonists","name":"glucagon like peptide 1 receptor agonists"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07140289","title":"Effect of Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RA) on Gastric Emptying","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":100,"lead_sponsor_name":"Wael Saasouh, MD","has_results":false},{"nct_id":"NCT06520540","title":"HDM1002 Tablets in Chinese Overweight and Obese Adult Subjects","phase":"PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":72,"lead_sponsor_name":"Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT07073053","title":"The Role of Glucagon-Like Peptide-1 Receptor Agonists in Coronary Artery Diseases and Their Potential Mechanisms","phase":"PHASE4","overall_status":"NOT_YET_RECRUITING","enrollment_count":60,"lead_sponsor_name":"Taipei Veterans General Hospital, Taiwan","has_results":false},{"nct_id":"NCT07014709","title":"Impact of GLP-1 Receptor Agonists on Patients With IPMN","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":30,"lead_sponsor_name":"Hôpital Fribourgeois","has_results":false}],"total":4},"guidelines":[],"source":"Drug Landscape verified database"}